Evidence map›Paper›PMID 39942986›Full record

ArticlePlants (Basel, Switzerland)2025

Characterization of a Topramezone-Resistant Rice Mutant TZR1: Insights into GST-Mediated Detoxification and Antioxidant Responses.

Shiyuan Hu, Kai Luo, Tao Tang, Guolan Ma, Yajun Peng, Yuzhu Zhang, Yang Liu, Lang Pan, Sifu Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shiyuan HuCollege of Plant Protection, Hunan Agricultural University, Changsha 410128, China.
Kai LuoCollege of Plant Protection, Hunan Agricultural University, Changsha 410128, China.
Tao TangInstitute of Plant Protection, Hunan Academy of Agricultural Sciences, Changsha 410125, China.ORCID 0000-0002-3128-673X
Guolan MaInstitute of Plant Protection, Hunan Academy of Agricultural Sciences, Changsha 410125, China.
Yajun PengInstitute of Plant Protection, Hunan Academy of Agricultural Sciences, Changsha 410125, China.
Yuzhu ZhangState Key Laboratory of Hybrid Rice, Hunan Hybrid Rice Research Center, Changsha 410125, China.
Yang LiuState Key Laboratory of Hybrid Rice, Hunan Hybrid Rice Research Center, Changsha 410125, China.
Lang PanCollege of Plant Protection, Hunan Agricultural University, Changsha 410128, China.
Sifu LiCollege of Plant Protection, Hunan Agricultural University, Changsha 410128, China.

Funding

the Hunan Agricultural Science and Technology Innovation Fund Project No.2024CX127the National Key Research and Development Program of China No. 2023YFD1401100the National Natural Science Foundation of China No. 32102239the Science and Technology Talent Support Project of Hunan Province No. 2023TJ-N11
6 · The paper itself

Abstract

Mutagenesis breeding, combined with the application of corresponding herbicides to develop herbicide-resistant rice germplasm, provides great promise for the management of weeds and weedy rice. In this study, a topramezone-resistant rice mutant, TZR1, was developed from the indica rice line Chuangyu 9H (CY9H) through radiation mutagenesis and topramezone selection. Dose-response curves revealed that the resistance index of TZR1 to topramezone was 1.94-fold compared to that of CY9H. The resistance mechanism of TZR1 was not due to target-site resistance. This resistance could be reversed by a specific inhibitor of glutathione

Indexed as

ATP-binding cassette transporterglutathione S-transferaseHPPDradiation mutagenesistopramezoneUDP-glycosyltransferase

Identifiers

PMID39942986
PMCPMC11819949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.